Evidence map›Paper›PMID 29026164›Full record

ArticleScientific reports2017

Production and evaluation of parathyroid hormone receptor

Xavier Charest-Morin, Patrice E Poubelle, François Marceau

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xavier Charest-MorinDivision of Infectious Disease and Immunity, CHU de Québec-Université Laval, Quebec City, QC, G1V 4G2, Canada.
Patrice E PoubelleDivision of Infectious Disease and Immunity, CHU de Québec-Université Laval, Quebec City, QC, G1V 4G2, Canada.
François MarceauDivision of Infectious Disease and Immunity, CHU de Québec-Université Laval, Quebec City, QC, G1V 4G2, Canada. francois.marceau@crchudequebec.ulaval.ca.ORCID 0000-0003-1691-6083
Université Laval · CAHôpital Saint-François d'Assise · CA

Funding

CIHR MOP-93773
6 · The paper itself

Abstract

Parathyroid hormone (PTH) can be C-terminally extended without significant affinity loss for the PTH

Indexed as

BiotinDNA-(Apurinic or Apyrimidinic Site) LyaseEndonucleasesHEK293 CellsHumansLuminolMultifunctional EnzymesPeroxidasePhenolReceptor, Parathyroid Hormone, Type 1APEX2 protein, humanBiotinDNA-(Apurinic or Apyrimidinic Site) LyaseEndonucleasesLuminolMultifunctional EnzymesPeroxidasePhenolPTH1R protein, humanReceptor, Parathyroid Hormone, Type 1

Identifiers

PMID29026164
PMCPMC5638942
OpenAlexW2763011196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.